US Archives - Page 12 of 205 - European Medical Journal

Pulmonologist reviewing lung imaging for idiopathic pulmonary fibrosis and inhaled treprostinil research.

ATS 2026: TETON-1 Inhaled Treprostinil Slows IPF Decline

Inhaled treprostinil slowed lung function decline in TETON-1, a Phase III trial in idiopathic pulmonary fibrosis.

Healthcare professional discussing GLP-1 weight loss and aesthetic treatment concerns with a patient.

SCALE 2026: GLP-1 Weight Loss Intensifies Aesthetic Care

GLP-1 weight loss may intensify aesthetic concerns linked to skin laxity, muscle tone, and body contouring.

Older adult discussing pulmonary tuberculosis outcomes and comorbidity risk with a healthcare professional.

Pulmonary Tuberculosis Outcomes Worsen with Comorbidities

Pulmonary tuberculosis outcomes worsened in older patients with diabetes, kidney disease, malignancy, or multimorbidity.

Doctor discussing gabapentinoids and asthma exacerbation risk with a patient with chronic pain

Gabapentinoids Linked to Higher Asthma Risk

Gabapentinoids may increase asthma exacerbation risk in adults treated for chronic or neuropathic pain.

Back view of a man’s head and neck, representing head and neck skin lesions and dermatology assessment.

SCALE 2026: Head and Neck Skin Lesions Need Closer Follow-Up

Head and neck skin lesions require precise excision to reduce recurrence and preserve cosmetic outcomes.

Clostridioides difficile Revisited: What Clinicians Need to Know

The treatment options for Clostridioides difficile are changing, with two FDA-approved microbiota products, discontinued therapies, and…

AMJ Microbiology & Infectious Diseases 4 [Supplement 4] 2026

This article provides an update on the treatment of Clostridioides difficile infection (CDI), combining key recent data with perspectives…

Bereaved family receiving support after end-of-life care for a young adult with cancer.

Young Adult Cancer Bereavement Raises Depression Risk in Family

Bereaved families of young adults with cancer face greater grief and depression after end-of-life care.

Older patient with cancer using a tablet during a healthcare consultation about digital health technophobia.

Digital Health Technophobia Divides Older Patients

Digital health technophobia varies widely among older patients with cancer, highlighting barriers to equitable digital cancer care.

Patient with Parkinson’s disease speaking with a neurologist about illness perception and emotional burden.

Key Factors That Shape Parkinson’s Disease Illness Perception

Parkinson’s disease perception was most negative among women, younger adults, and patients with longer disease duration.